Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT01266538

Inflammatory Bowel Disease(IBD)Database

This will be a comprehensive epidemiological, clinical, endoscopic and histological database for inflammatory bowel diseases patients in our medical center that will further provide clinical and basic investigations.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Inflammatory Bowel Disease Digestive System Diseases Gastroenteritis Gastrointestinal Diseases Inflammatory Bowel Diseases Intestinal Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tel Aviv Sourasky Medical Center

Tel Aviv, 64239, Israel

Location contact

Hagit Tulchinsky, MD

SUB_INVESTIGATOR

Henit Yanai, MD

SUB_INVESTIGATOR

About this study

Inflammatory bowel diseases (IBD), which include Crohn's disease (CD), ulcerative colitis (UC), undefined IBD and pouchitis (in patients who required IPAA for their colitis) affects about two million people in the world. At this time there is no definitive cure and current treatment is aimed at managing the symptoms and inflammation that accompany these diseases. These diseases are predominantly chronic, and patients may experience various gastrointestinal symptoms depending on the location, nature, and extent of their disease. Both genetic and environmental factors play etiological roles. The overall goal of our research is to understand the etiology and course of these diseases in order to prevent and to manage cases more effectively. In order to do so we are aiming at building a comprehensive database that will include detailed clinical data conjoined with dedicated research information and collection of biological specimens that will target the gut epithelium immune system, the microbiota and specific genetic risk factors.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of IBD Regular treatment and follow up in Tel Aviv Sourasky medical center Fap (familial polyposis)patients after a large bowel resection, as controls Family members of IBD patients as controls Patients with Irritable Bowel Syndrome (IBS), as controls -

Exclusion criteria

pregnancy age<18 years

-

Treatment and study plan

Primary outcomes

  1. flactuations in gastrointestinal inflammation

    Time frame: ongoing, up to 4 times a year

Secondary outcomes

  1. development of IBD-related morbidity and complications over time

    Time frame: ongoing, up to 4 times a year

Study contacts

Contact information is provided by the study sponsor or research team.

Iris Dotan, MD PhD

CONTACT

[email protected]

972-3-6947305

Sponsors and collaborators

Lead sponsor

Tel-Aviv Sourasky Medical Center

Other Gov

Registry information

Official study title

Epidemiologic, Clinical, Endoscopic and Histological Database of Patients With Inflammatory Bowel Disease (IBD)

Acronym: IBD

Important dates

Study start
2011
Primary completion
2026
Study completion
2026
First posted
Dec 24, 2010
Registry last updated
Dec 24, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.